5/30
04:34 pm
syre
Form 8-K Spyre Therapeutics, Inc. For: May 30
Low
Report
Form 8-K Spyre Therapeutics, Inc. For: May 30
5/16
04:11 pm
syre
Form 4 Spyre Therapeutics, Inc. For: May 14 Filed by: Kiselak Tomas
Neutral
Report
Form 4 Spyre Therapeutics, Inc. For: May 14 Filed by: Kiselak Tomas
5/16
04:11 pm
syre
Form 4 Spyre Therapeutics, Inc. For: May 14 Filed by: Albers Jeffrey W.
Neutral
Report
Form 4 Spyre Therapeutics, Inc. For: May 14 Filed by: Albers Jeffrey W.
5/16
04:11 pm
syre
Form 4 Spyre Therapeutics, Inc. For: May 14 Filed by: Milligan Sandra
Neutral
Report
Form 4 Spyre Therapeutics, Inc. For: May 14 Filed by: Milligan Sandra
5/16
04:10 pm
syre
Form 4 Spyre Therapeutics, Inc. For: May 14 Filed by: HENDERSON MICHAEL THOMAS
Neutral
Report
Form 4 Spyre Therapeutics, Inc. For: May 14 Filed by: HENDERSON MICHAEL THOMAS
5/16
04:10 pm
syre
Form 4 Spyre Therapeutics, Inc. For: May 14 Filed by: Stelzer Laurie
Neutral
Report
Form 4 Spyre Therapeutics, Inc. For: May 14 Filed by: Stelzer Laurie
5/16
04:06 pm
syre
Form 3 Spyre Therapeutics, Inc. For: May 14 Filed by: Milligan Sandra
Neutral
Report
Form 3 Spyre Therapeutics, Inc. For: May 14 Filed by: Milligan Sandra
5/15
04:13 pm
syre
Form 424B3 Spyre Therapeutics, Inc.
Medium
Report
Form 424B3 Spyre Therapeutics, Inc.
5/15
07:41 am
syre
Form 8-K Spyre Therapeutics, Inc. For: May 13
Medium
Report
Form 8-K Spyre Therapeutics, Inc. For: May 13
5/9
04:13 pm
syre
Form 8-K Spyre Therapeutics, Inc. For: May 09
Medium
Report
Form 8-K Spyre Therapeutics, Inc. For: May 09
5/9
04:10 pm
syre
Form 10-Q Spyre Therapeutics, Inc. For: Mar 31
Medium
Report
Form 10-Q Spyre Therapeutics, Inc. For: Mar 31
4/30
11:38 am
syre
Form SEC STAFF LETTER Spyre Therapeutics, Inc.
Low
Report
Form SEC STAFF LETTER Spyre Therapeutics, Inc.
4/30
11:37 am
syre
Form SEC STAFF LETTER Spyre Therapeutics, Inc.
Low
Report
Form SEC STAFF LETTER Spyre Therapeutics, Inc.
4/30
06:09 am
syre
Form EFFECT Spyre Therapeutics, Inc.
Medium
Report
Form EFFECT Spyre Therapeutics, Inc.
4/25
04:56 pm
syre
Form 4 Spyre Therapeutics, Inc. For: Apr 25 Filed by: Kiselak Tomas
Medium
Report
Form 4 Spyre Therapeutics, Inc. For: Apr 25 Filed by: Kiselak Tomas
4/25
04:40 pm
syre
Form SC 13D/A Spyre Therapeutics, Inc. Filed by: Fairmount Funds Management LLC
Medium
Report
Form SC 13D/A Spyre Therapeutics, Inc. Filed by: Fairmount Funds Management LLC
4/25
04:22 pm
syre
Form 8-K Spyre Therapeutics, Inc. For: Apr 23
Medium
Report
Form 8-K Spyre Therapeutics, Inc. For: Apr 23
4/23
06:22 pm
syre
Form SC 13G/A Spyre Therapeutics, Inc. Filed by: Avoro Capital Advisors LLC
Low
Report
Form SC 13G/A Spyre Therapeutics, Inc. Filed by: Avoro Capital Advisors LLC
4/19
06:03 am
syre
Form S-1 Spyre Therapeutics, Inc.
Medium
Report
Form S-1 Spyre Therapeutics, Inc.
4/2
04:38 pm
syre
Form ARS Spyre Therapeutics, Inc. For: Dec 31
Low
Report
Form ARS Spyre Therapeutics, Inc. For: Dec 31
4/2
06:04 am
syre
Form EFFECT Spyre Therapeutics, Inc.
Medium
Report
Form EFFECT Spyre Therapeutics, Inc.
4/2
06:04 am
syre
Form EFFECT Spyre Therapeutics, Inc.
Medium
Report
Form EFFECT Spyre Therapeutics, Inc.
4/1
04:07 pm
syre
Form DEF 14A Spyre Therapeutics, Inc. For: May 13
Medium
Report
Form DEF 14A Spyre Therapeutics, Inc. For: May 13
3/27
06:04 am
syre
Form S-1/A Spyre Therapeutics, Inc.
Low
Report
Form S-1/A Spyre Therapeutics, Inc.
3/27
06:03 am
syre
Form POS AM Spyre Therapeutics, Inc.
Low
Report
Form POS AM Spyre Therapeutics, Inc.